ArticleTherapeutic advances in musculoskeletal disease2025
Safety outcomes in 2132 Danish patients with inflammatory arthritis treated with biosimilar infliximab (GP1111) in routine care.
Hafsah Nabi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.